On the evening of July 20, 2021, the first phase of the express interview on the frontier research of primary health and general medicine jointly organized by the Family Medicine and Community Health (FMCH) editorial department and the editorial department of the Chinese Journal of General Medicine went on smoothly.
Cao Xinyang, FMCH media editor, interviewed the author of the paper, associate professor of the Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, and China Journal of West China Hospital, Sichuan University on the study of clinical practice guidelines for SGLT-2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes. Ms. Li Sheyu, Deputy Director of the Laboratory of Evidence-Based Evaluation and Quick Guide of the Center for Evidence-based Medicine.
Click here to watch the video